• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    High-Throughput Polymorphism Detection Core

    The High-Throughput Polymorphism Detection Core (HTPC) provides services to DF/HCC investigators conducting molecular analyses of germline DNA collected as part of a wide range of investigations into the molecular epidemiology of cancer, including Genome Wide Association Studies (GWAS)

    Forty-five new members join DF/HCC

    Forty-five individuals have recently joined DF/HCC

    Phase 1b/2 trial targets stroma barrier in metastatic pancreatic cancer

    Pancreatic cancer has literally walled itself off for decades from efforts to find an effective drug therapy

    DF/HCC Collaborative RNAi Core offers new services

    The DF/HCC Collaborative RNAi Core is pleased to announce the availability of three new miRNA-targeted libraries and a new laser scanning cytometer

    Trials target abnormal fusion gene in lung cancer

    Non-small cell lung cancer (NSCLC), the most commonly fatal malignancy in the United States, accounts for approximately 85 percent of all lung cancer

    Ovarian cancer research takes center stage

    Most women with ovarian cancer are diagnosed in their 60s and 70s with advanced stage disease that has spread throughout the abdomen

    New Core: Recombinant Protein Expression and Purification

    The Recombinant Protein Expression and Purification (RPrEP) Core was launched in 2009 to provide a cost-effective resource to the DF/HCC community for expression and purification of recombinant fusion proteins necessary for pre-clinical studies as well as for basic mechanistic studies by immunologists and cancer biologists

Displaying results 78 to 84 out of 207